Needham & Company
-
Needham & Company Downgrades Imperva (IMPV) to Hold
-
Needham & Company Reiterates Buy Following Imperva's (IMPV) 4Q Beat and Raise
-
Needham & Company Reiterates Buy on Imperva (IMPV) Following Analyst Day.
-
Imperva (IMPV) PT Raised to $88 at Needham & Company Amid Strong June Quarter
-
Needham & Company Raises PT Sharply as Imperva (IMPV) Raises Guidance
-
Notable Analyst Rating Changes 11/24: (SCTY) (LL) (KATE) Upgraded; (CBI) (VZ) (XOM) Downgraded
-
Needham & Company Starts Imperva (IMPV) at Buy
-
Needham & Company on Security Software: Observations from RSA Conference

